Ashraf Z. Badros, MB, ChB, discusses the next steps following the phase 3 AURIGA trial of daratumumab and lenalidomide vs lenalidomide maintenance in patients with newly diagnosed multiple myeloma.

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

A predatory Sheffield crime gang took over the flat of a vulnerable man with paranoid schizophrenia, forcing him to remain ...